I found this on another Pharmex chat www.stockhouse.com, it is good.
Investors should look for healthcare service companies or therapeutics companies with
products already on the market. These
companies certainly bode well for the sector and perhaps point to a more robust
1999,we believe they are also indicative of a
new investment philosophy for healthcare. Investors are indicating that the healthcare
service based companies and therapeutic companies with product on the market are the
most appealing of those in the sector because they have little or no product development
risk and are on a much faster track to revenue and earnings than the development stage
therapeutics companies.In the meantime, investors have been looking at
non-therapeutics companies (e.g.,services-based companies or healthcare related
providers) or companies with products already being marketed. If investors are looking
to play the healthcare sector,but do not want the relative greater risk of development
stage companies and believe the mid/large cap companies are expensive, the "healthcare
services" sector offers an alternative. This grouping includes companies such as MDS
Inc., TLC The Laser Center Inc., DC DiagnostiCare Inc., Phoenix International Life
Sciences, Pharmex Industries Inc., Canadian Medical Labs, Patheon Inc., Extendicare
Inc., TechniLab Inc.,and Counsel Corporation. These companies often are bypassed in
the sector in favour of more exciting healthcare stocks and, as a result, values may be
found. |
